{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:01:33Z","timestamp":1777878093036,"version":"3.51.4"},"reference-count":5,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Rare Tumors"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1177\/20363613231205749","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T09:36:21Z","timestamp":1695807381000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["\u201cA beacon of hope for relapsed multiple myeloma patients: TALVEY\u2122\u201d"],"prefix":"10.1177","volume":"15","author":[{"given":"Nawal","family":"Khaliq","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2277-0183","authenticated-orcid":false,"given":"Rumaisa","family":"Riaz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleeza","family":"Hasan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Karachi Medical and Dental College, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Alauddin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Karachi Medical and Dental College, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,9,27]]},"reference":[{"key":"bibr1-20363613231205749","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2020-0141"},{"key":"bibr2-20363613231205749","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014611"},{"key":"bibr3-20363613231205749","unstructured":"Center for Drug Evaluation and Research. Talquetamab-tgvs for relapsed or refractory multiple myeloma. USA: U.S. Food and Drug Administration. https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-talquetamab-tgvs-relapsed-or-refractory-multiple-myeloma (accessed 5 September 2023)."},{"key":"bibr4-20363613231205749","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020407"},{"key":"bibr5-20363613231205749","unstructured":"The Janssen Pharmaceutical Companies of Johnson & Johnson. U.S. FDA approves TALVEYTM (talquetamab-tgvs), a first-in-class bispecific therapy for the treatment of patients with heavily pretreated multiple myeloma. USA: PR Newswire: press release distribution, targeting, monitoring and marketing, 2023. https:\/\/www.prnewswire.com\/news-releases\/us-fda-approves-talvey-talquetamab-tgvs-a-first-in-class-bispecific-therapy-for-the-treatment-of-patients-with-heavily-pretreated-multiple-myeloma-301897786.html (accessed 5 September 2023)."}],"container-title":["Rare Tumors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20363613231205749","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20363613231205749","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20363613231205749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:11:30Z","timestamp":1777590690000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20363613231205749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":5,"alternative-id":["10.1177\/20363613231205749"],"URL":"https:\/\/doi.org\/10.1177\/20363613231205749","relation":{},"ISSN":["2036-3613","2036-3613"],"issn-type":[{"value":"2036-3613","type":"print"},{"value":"2036-3613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]},"article-number":"20363613231205749"}}